Treier, Anne-Katrin
Labarga, Sara Zaplana
Ginsberg, Claudia
Kohl, Lea Teresa
Görtz-Dorten, Anja
Ravens-Sieberer, Ulrike
Kaman, Anne
Banaschewski, Tobias
Aggensteiner, Pascal-M.
Hanisch, Charlotte
Kölch, Michael
Daunke, Andrea
Roessner, Veit
Kohls, Gregor
Döpfner, Manfred
,
Bernheim, Dorothee
Bienioschek, Stefanie
Boecker, Maren
Brandeis, Daniel
Butz, Kristina
Fegert, Jörg M.
Giller, Franziska
Goldbeck, Carolina
Hellmich, Martin
Igel, Christine
Junghänel, Michaela
Ritschel, Anne
Schroth, Jennifer
Schüller, Anne
Steiner, Marion
Uhlmann, Anne
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 27 November 2023
Accepted: 4 June 2024
First Online: 20 June 2024
Declarations
:
: Approval for the ADOPT Online study was obtained from the ethics committee of the University of Cologne (18–033), the University Hospital of Dresden (EK 35409218), the University Hospital of Mannheim (2018-554 N-MA), and the University Hospital of Ulm (297/18). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The parents of all participating children and adolescents provided informed consent for participation.
: The parents of all participating children and adolescents provided informed consent for publication.
: AGD receives royalties from publishing companies as an author of books and treatment manuals on child behavioral therapy and of assessment manuals, including the treatment manuals evaluated in this trial. She receives income as a consultant for Child Behavior Therapy at the National Association of Statutory Health Insurance Physicians. She also receives consulting income and research support from Medice and eyelevel GmbH. TB served in an advisory or consultancy role for eyelevel GmbH, Infectopharm, Medice, Neurim Pharmaceuticals, Oberberg GmbH, and Takeda. He received conference support or speaker’s fees from Janssen, Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press; the present work is unrelated to these relationships. CH receives royalties from a publishing company as the author of a treatment manual. MK receives royalties from publishing companies as an author of books. He served as PI or CI in clinical trials of Lundbeck, Pascoe, and Janssen-Cilag. He served as a scientific advisor for Janssen. The present work is unrelated to the above grants and relationships. VR has received lecture fees from Infectopharm and Medice. He has carried out clinical trials in cooperation with Servier and Shire Pharmaceuticals/Takeda. The present work is unrelated to the above grants and relationships. MD received royalties from publishing companies as an author of books and treatment manuals on child behavioral therapy and of assessment manuals published by Beltz, Elsevier, Enke, Guilford, Hogrefe, Huber, Kohlhammer, Schattauer, Springer, and Wiley. He received income as a consultant for Child Behavior Therapy at the National Association of Statutory Health Insurance Physicians. He also received consulting income and research support from Lilly, Medice, Takeda, and eyelevel GmbH. AT, SZL, CG, LTK, URS, AK, PA, AD, and GK declare no competing interests.